364
Views
5
CrossRef citations to date
0
Altmetric
Articles

Circadian clock, cell cycle, and breast cancer: an updated review

, , , &
Pages 353-369 | Received 19 Oct 2016, Accepted 01 Nov 2016, Published online: 30 Nov 2016

References

  • Akashi M, Takumi T. 2005. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol. 12:441–448.10.1038/nsmb925
  • Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. 2001. Differential functionsof mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron. 30:525–536.10.1016/S0896-6273(01)00302-6
  • Barnard AR, Nolan PM. 2008. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet. 4:e1000040.10.1371/journal.pgen.1000040
  • Barnes JW, Tischkau SA, Barnes JA, Mitchell JW, Burgoon PW, Hickok JR, Gillette MU. 2003. Requirement of mammalian timeless for circadian rhythmicity. Science. 302:439–442.10.1126/science.1086593
  • Ben-Shlomo R. 2014. Chronodisruption, cell cycle checkpoints and DNA repair. Ind J Exp Biol. 52:399–403.
  • Bieler J, Cannavo R, Gustafson K, Gobet D, Naef F. 2014. Robust synchronization of coupled circadian cell cycle oscillators in single mammalian cells. Mol Syst Biol. 10:739.10.15252/msb.20145218
  • Bjarnason GA, Jordan R. 2000. Circadian variation of cell proliferation and cell cycle protein expression in man: clinical implications. Prog Cell Cycle Res. 4:193–206.10.1007/978-1-4615-4253-7
  • Bolige A, Hagiwara S, Zhang Y, Goto K. 2005. Circadian G2 arrest as related to circadian gating of cell population growth in euglena. Plant Cell Physiol. 46:931–936.10.1093/pcp/pci100
  • Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, Malgrange B. 2009. Cell “circadian” cycle; new role for mammalian core clock genes. Cell Cycle. 8:832–837.10.4161/cc.8.6.7869
  • Bracci M, Manzella N, Copertaro A, Staffolani S, Strafella E, Barbaresi M, Copertaro B, Rapisarda V, Valentino M, Santarelli L. 2014. Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-β-estradiol levels. Scand J Work Environ Health. 40:295–304.10.5271/sjweh.3414
  • Brochier C, Dennis G, Rivieccio MA, McLaughlin K, Coppola G, Ratan RR, Langley B. 2013. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci. 33:8621–8632.10.1523/JNEUROSCI.5214-12.2013
  • Brown SA, Azzi A. 2013. Peripheral circadian oscillators in mammals. Handb Exp Pharmacol. 217:45–66.10.1007/978-3-642-25950-0
  • Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA. 2000. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 103:1009–1017.10.1016/S0092-8674(00)00205-1
  • Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI, Draetta GF, Pagano M. 2007. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science. 316:900–904.10.1126/science.1141194
  • Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R, Schmidt M, Rahnenführer J, Oster H, Hengstler JG. 2014. Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 13:3282–3291.10.4161/15384101.2014.954454
  • Caldon CE, Sutherland RL, Musgrove E. 2010. Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle. 9:1918–1928.10.4161/cc.9.10.11474
  • Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, Fox SB. 2004. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer. 91:954–958.10.1038/sj.bjc.6602059
  • Chekulaeva M, Filipowicz W. 2009. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol. 21:452–460.10.1016/j.ceb.2009.04.009
  • Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. 2005. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 26:1241–1246.
  • Cheng HY, Papp JW, Varlamova O, Dziema H, Russell B, Curfman JP, Nakazawa T, Shimizu K, Okamura H, Impey S, Obrietan K. 2007. microRNA modulation of circadian-clock period and entrainment. Neuron. 54:813–829.10.1016/j.neuron.2007.05.017
  • Chu LW, Zhu Y, Yu K, Zheng T, Yu H, Zhang Y, Sesterhenn I, Chokkalingam AP, Danforth KN, Shen MC, et al. 2008. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis. 11:342–348.10.1038/sj.pcan.4501024
  • Ciarleglio CM, Ryckman KK, Servick SV, Hida A, Robbins S, Wells N, Hicks J, Larson SA, Wiedermann JP, Carver K, et al. 2008. Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms. 23:330–340.10.1177/0748730408320284
  • De-Bruyne JP, Noton E, Lambert CM, Maywood ES, Weaver DR, Reppert SM. 2006. A clock shock: mouse CLOCK is not required for circadian oscillator function. Neuron. 50:465–477.10.1016/j.neuron.2006.03.041
  • Dekens MP, Santoriello C, Vallone D, Grassi G, Whitmore D, Foulkes NS. 2003. Light regulates the cell cycle in zebrafish. Curr Biol. 13:2051–2057.10.1016/j.cub.2003.10.022
  • Doi M, Hirayama J, Sassone-Corsi P. 2006. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 125:497–508.10.1016/j.cell.2006.03.033
  • Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K. 2007. Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res. 67:9694–9703.10.1158/0008-5472.CAN-07-1522
  • Eide EJ, Woolf MF, Kang H, Woolf P, Hurst W, Camacho F, Vielhaber EL, Giovanni A, Virshup DM. 2005. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol. 25:2795–2807.10.1128/MCB.25.7.2795-2807.2005
  • Engelen E, Janssens RC, Yagita K, Smits VAJ, van der Horst GTJ, Tamanini F. 2013. Mammalian TIMELESS is involved in period determination and DNA damage-dependent phase advancing of the circadian clock. PLoS ONE. 8–e56623.
  • Feillet C, Krusche P, Tamanini F, Janssens RC, Downey MJ, Martin P, Teboul M, Saito S, Lévi FA, Bretschneider T, et al. 2014. Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle. Proc Nat Acad Sci. 111:9828–9833.10.1073/pnas.1320474111
  • Feillet C, van-der-Horst GT, Levi F, Rand DA, Delaunay F. 2015. Coupling between the circadian clock and cell cycle oscillators: implication for healthy cells and malignant growth. Front Neurol. 6:1–7.
  • Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, Grundy A, Erren TC. 2011. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 77:430–436.10.1016/j.mehy.2011.06.002
  • Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG, Zhu Y. 2011. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Mol carcinog. 51:923–929.
  • Fu L, Kettner NM. 2013. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci. 119:221–282.10.1016/B978-0-12-396971-2.00009-9
  • Fu L, Lee CC. 2003. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361.10.1038/nrc1072
  • Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. 2005. The molecular clock mediates leptin-regulated bone formation. Cell. 122:803–815.10.1016/j.cell.2005.06.028
  • Fu L, Pelicano H, Liu J, Huang P, Lee C. 2002. The circadian gene Period 2 plays an important role intumor suppression and DNA damage response in vivo. Cell. 111:41–50.10.1016/S0092-8674(02)00961-3
  • Gallego M, Eide EJ, Woolf MF, Virshup DM, Forger DB. 2006. An opposite role for tau in circadian rhythms revealed by mathematical modeling. Proc Nat Acad Sci. 103:10618–10623.10.1073/pnas.0604511103
  • Gauger MA, Sancar A. 2005. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res. 65:6828–6834.10.1158/0008-5472.CAN-05-1119
  • Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, Takahashi JS, Weitz CJ. 1998. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280:1564–1569.10.1126/science.280.5369.1564
  • Gerard C, Goldbeter A. 2012. Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms. PLoS Comput Biol. 8:e1002516.10.1371/journal.pcbi.1002516
  • Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. 2006. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 22:375–382.10.1016/j.molcel.2006.03.038
  • Geyfman M, Kumar V, Liu Q, Ruiz R, Gordon W, Espitia F, Cam E, Millar SE, Smyth P, Ihler A, Takahashi JS, Andersen B. 2012. Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis. Proc Nat Acad Sci. 109:11758–11763.10.1073/pnas.1209592109
  • Godinho SI, Maywood ES, Shaw L, Tucci V, Barnard AR, Busino L, Pagano M, Kendall R, Quwailid MM, Romero MR. 2007. The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science. 316:897–900.10.1126/science.1141138
  • Gossan NC, Zhang F, Guo B, Jin D, Yoshitane H, Yao A, Glossop N, Zhang YQ, Fukada Y, Meng QJ. 2014. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res. 42:5765–5775.10.1093/nar/gku225
  • Goto K, Johnson CH. 1995. Is the cell division cycle gated by the circadian clock? The case of Chlamydomonas reinhardii. J Cell Biol. 129:1061–1069.10.1083/jcb.129.4.1061
  • Gréchez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. 2008. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem. 283:4535–4542.10.1074/jbc.M705576200
  • Guillaumond F, Dardente H, Giguere V, Cermakian N. 2005. Differential control of bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms. 20:391–403.10.1177/0748730405277232
  • Guo Z, Kumagai A, Wang SX, Dunphy WG. 2000. Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 14:2745–2756.10.1101/gad.842500
  • Halberg F, Zander HA, Houglum MW, Muhlemann HR. 1954. Daily variations in tissue mitoses, blood eosinophils and rectal temperatures of rats. Am J Physiol. 177:361–366.
  • Hawkins GA, Meyers DA, Bleecker ER, Pack AI. 2008. Identification of coding polymorphisms in human circadian rhythm genes PER1, PER2, PER3, Clock, ARNTL, CRY1, CRY2 and TIMELESS in a multi-ethnic screening panel. DNA Seq. 19:44–49.10.1080/10425170701322197
  • Hirayama J, Sahar S, Grimaldi B, Tamaru T, Takamatsu K, Nakahata Y, Sassone-Corsi P. 2007. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature. 450:1086–1090.10.1038/nature06394
  • Hirota T, Lee JW, Lewis WG, Zhang EE, Breton G, Liu X, Garcia M, Peters EC, Etchegaray JP, Traver D, Schultz PG, Kay SA. 2010. High-throughput chemical screen identi fi es a novel potent modulator of cellular circadian rhythms and reveals CKIalpha as a clock regulatory kinase. PLoS Biol. 8:e1000559.10.1371/journal.pbio.1000559
  • Hoberg JE, Popko AE, Ramsey CS, Mayo MW. 2006. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol. 26:457–471.10.1128/MCB.26.2.457-471.2006
  • Hoffman AE, Zheng T, Ba Y, Zhu Y. 2008. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res. 6:1461–1468.10.1158/1541-7786.MCR-07-2094
  • Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. 2009. Clock-cancer connection in non-hodgkin’s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res. 69:3605–3613.10.1158/0008-5472.CAN-08-4572
  • Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. 2010a. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 70:1459–1468.10.1158/0008-5472.CAN-09-3798
  • Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. 2010b. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res. 3:539548.
  • Hogenesch JB, Gu YZ, Jain S, Bradfield CA. 1998. The basic helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Nat Acad Sci. 95:5474–5479.10.1073/pnas.95.10.5474
  • Hong HK, Huang W, Ramsey KM, Marcheva B, Bass J. 2012. Clock genes and energy metabolism. In: Shiromani PJ, Horvath T, Redline S and van Cauter E, Editors. Sleep Loss and Obesity: Intersecting Epidemics. New York: Springer; p.13–32.10.1007/978-1-4614-3492-4
  • Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F, Liu Y, Ao X, Chang AK, Wu H. 2011. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS ONE. 6:e23046.10.1371/journal.pone.0023046
  • Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K. 2002. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 419:841–844.10.1038/nature01123
  • Hsu MC, Huang CC, Choo KB, Huang CJ. 2007. Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells. Biochem Biophys Res Commun. 360:257–262.10.1016/j.bbrc.2007.06.042
  • Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. 2006. Circadian gene mPer 2 overexpression induces cancer cell apoptosis. Cancer Sci. 97:589–596.10.1111/cas.2006.97.issue-7
  • Hunt T, Sassone-Corsi P. 2007. Riding tandem: circadian clocks and the cell cycle. Cell. 129:461–464.10.1016/j.cell.2007.04.015
  • Im JS, Jung BH, Kim SE, Lee KH, Lee JK. 2010. Per3, a circadian gene, is required for Chk2 activation in human cells. FEBS Lett. 584:4731–4734.10.1016/j.febslet.2010.11.003
  • Kadener S, Menet JS, Sugino K, Horwich MD, Weissbein U, Nawathean P, Vagin VV, Zamore PD, Nelson SB, Rosbash M. 2009. A role for microRNAs in the drosophila circadian clock. Genes Dev. 23:2179–2191.10.1101/gad.1819509
  • Kamdar BB, Tergas AI, Mateen FJ, Bhayani NH, Oh J. 2013. Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 138:291–301.10.1007/s10549-013-2433-1
  • Kang TH, Reardon JT, Kemp M, Sancar A. 2009. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Nat Acad Sci. 106:2864–2867.10.1073/pnas.0812638106
  • Kang TH, Lindsey-Boltz LA, Reardon JT, Sancar A. 2010. Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase. Proc Nat Acad Sci. 107:4890–4895.10.1073/pnas.0915085107
  • Karantanos T, Theodoropoulos G, Pektasides D, Gazouli M. 2014. Clock genes: their role in colorectal cancer. World J Gastroenterol. 20:1986–1992.10.3748/wjg.v20.i8.1986
  • Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL. 2006. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol Endocrinol. 20:1479–1493.10.1210/me.2005-0531
  • King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP, Steeves TD, Vitaterna MH, Kornhauser JM, Lowrey PL, et al. 1997. Positional cloning of the mouse circadian clock gene. Cell. 89:641–653.10.1016/S0092-8674(00)80245-7
  • Ko CH, Takahashi JS. 2006. Molecular components of the mammalian circadian clock. Hum Mol Genet. 15:R271–R277.10.1093/hmg/ddl207
  • Kochan DZ, Kovalchuk O. 2015. Circadian disruption and breast cancer: an epigenetic link? Oncotarget. 6:16866–16882.10.18632/oncotarget
  • Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, Buch T, Birchler T, Mueller A, Albrecht U, Contaldo C, Brown SA. 2013. NONO couples the circadian clock to the cell cycle. Proc Nat Acad Sci. 110:1592–1599.10.1073/pnas.1213317110
  • Kuo SJ, Chen ST, Yeh KT, Hou MF, Chang YS, Hsu NC, Chang JG. 2009. Disturbance of circadian gene expression in breast cancer. Virchows Arch. 454:467–474.10.1007/s00428-009-0761-7
  • Laranjeiro R, Tamai TK, Peyric E, Krusche P, Ott S, Whitmore D. 2013. Cyclin-dependent kinase inhibitor p20 controls circadian cell-cycle timing. Proc Nat Acad Sci. 110:6835–6840.10.1073/pnas.1217912110
  • Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. 2001. Posttranslational mechanisms regulate the mammalian circadian clock. Cell. 107:85567.
  • Lee HM, Chen R, Kim H, Etchegaray JP, Weaver DR, Lee C. 2011. The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1. Proc Nat Acad Sci. 108:16451–16456.10.1073/pnas.1107178108
  • Li S, Ao X, Wu H. 2013. The role of circadian rhythm in breast cancer. Chin J Cancer Res. 25:442–450.
  • Li Y, Shen Q, Kim HT, Bissonnette RP, Lamph WW, Yan B, Brown PH. 2011. The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor. Breast Cancer Res Treat. 128:667–677.10.1007/s10549-010-1083-9
  • Li Y, Xie M, Song X, Gragen S, Sachdeva K, Wan Y, Yan B. 2003. DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J Biol Chem. 278:16899–16907.10.1074/jbc.M300596200
  • Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, Kay SA. 2008. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 4:e1000023.10.1371/journal.pgen.1000023
  • Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, et al. 2000. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14:1448–1459.
  • Liu Y, Miao Y, Wang J, Lin X, Wang L, Xu HT, Wang EH. 2013. DEC1 is positively associated with the malignant phenotype of invasive breast cancers and negatively correlated with the expression of claudin-1. Int J Mol Med. 31:855–860.
  • Liu Y, Sato F, Kawamoto T, Fujimoto K, Morohashi S, Akasaka H, Kondo J, Wu Y, Noshiro M, Kato Y, Kijima H. 2010. Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells. Genes Cells. 15:315–325.10.1111/gtc.2010.15.issue-4
  • Lowrey PL, Takahashi JS. 2004. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet. 5:407–441.10.1146/annurev.genom.5.061903.175925
  • Lowrey PL, Takahashi JS. 2011. Genetics of circadian rhythms in mammalian model organisms. Adv Genet. 74:175–230.
  • Maier B, Kramer A. 2013. A NONO-gate times the cell cycle. Proc Nat Acad Sci. 110:1565–1566.10.1073/pnas.1221057110
  • Mao B, Zhao G, Lv X, Chen HZ, Xue Z, Yang B, Liu DP, Liang CC. 2011. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association. Int J Biochem Cell Biol. 43:1573–1581.10.1016/j.biocel.2011.07.006
  • Masri S, Cervantes M, Sassone-Corsi P. 2013. The circadian clock and cell cycle: interconnected biological circuits. Curr Opin Cell Biol. 25:730–734.10.1016/j.ceb.2013.07.013
  • Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. 2003. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 302:255–259.10.1126/science.1086271
  • Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM, Sládek M, Semikhodskii AS, Glossop NR, Piggins HD, et al. 2008. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron. 58:78–88.10.1016/j.neuron.2008.01.019
  • Miki T, Xu Z, Chen-Goodspeed M, Liu M, Van-Oort-Jansen A, Rea MA, Zhao Z, Lee CC, Chang KS. 2012. PML regulates PER2 nucrlear localization and circadian function. EMBO J. 31:1427–1439.10.1038/emboj.2012.1
  • Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB, Takahashi JS. 2010. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci USA. 104:3342–3347.
  • Mohawk JA, Green CB, Takahashi JS. 2012. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci. 35:445–462.10.1146/annurev-neuro-060909-153128
  • Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. 2012. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 131:2547–2552.10.1002/ijc.v131.11
  • Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, Basso G, Leo G, Rosato A, Bicciato S, Cordenonsi M, Piccolo S. 2012. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 487:380–384.10.1038/nature11207
  • Mori T, Binder B, Johnson CH. 1996. Circadian gating of cell division in cyanobacteria growing with average doubling times of less than 24 hours. Proc Nat Acad Sci. 93:10183–10188.10.1073/pnas.93.19.10183
  • Mori T, Johnson CH. 2001. Independence of circadian timing from cell division in cyanobacteria. J Bacteriol. 183:2439–2444.10.1128/JB.183.8.2439-2444.2001
  • Nagel R, Clijsters L, Agami R. 2009. The miRNA-192/194 cluster regulates the Period gene family and the circadian clock. FEBS J. 276:5447–5455.10.1111/j.1742-4658.2009.07229.x
  • Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. 2004. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell. 119:693–705.10.1016/j.cell.2004.11.015
  • Nakashima A, Kawamoto T, Honda KK, Ueshima T, Noshiro M, Iwata T, Fujimoto K, Kubo H, Honma S, Yorioka N, et al. 2008. DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol. 28:4080–4092.10.1128/MCB.02168-07
  • Nigg EA. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. BioEssays. 17:471–480.10.1002/(ISSN)1521-1878
  • Oishi K, Miyazaki K, Kadota K, Kikuno R, Nagase T, Atsumi G, Ohkura N, Azama T, Mesaki M, Yukimasa S. 2003. Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes. J Biol Chem. 278:41519–41527.10.1074/jbc.M304564200
  • Osborne CK. 1998. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat. 51:227–238.10.1023/A:1006132427948
  • Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. 2002. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 109:307–320.10.1016/S0092-8674(02)00722-5
  • Peyric E, Moore HA, Whitmore D. 2013. Circadian clock regulation of the cell cycle in the zebrafish intestine. PLoS One. 8:e73209.10.1371/journal.pone.0073209
  • Preitner N, Damiolam F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. 2002. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110:251–260.10.1016/S0092-8674(02)00825-5
  • Proteau A, Blier S, Albert AL, Lavoie SB, Traish AM, Vincent M. 2005. The multifunctional nuclear protein p54nrb is multi phosphorylated in mitosis and interacts with the mitotic regulator Pin1. J Mol Biol. 346:1163–1172.10.1016/j.jmb.2004.12.034
  • Qu F, Qiao Q, Wang N, Ji G, Zhao H, He L, Wang H, Bao G. 2016. Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients. Sci Rep. 6:22424.10.1038/srep22424
  • Raivich G. 2008. c-Jun expression, activation and function in neural cell death, inflammation and repair. J Neurochem. 107:898–906.
  • Reick M, Garcia JA, Dudley C, McKnight SL. 2001. NPAS2: an analog of clock operative in the mammalian forebrain. Science. 293:506–509.10.1126/science.1060699
  • Reischl S, Vanselow K, Westermark PO, Thierfelder N, Maier B, Herzel H, Kramer A. 2007. Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J Biol Rhythms. 22:375–386.10.1177/0748730407303926
  • Reppert SM, Weaver DR. 2002. Coordination of circadian timing in mammals. Nature. 418:935–941.10.1038/nature00965
  • Sahar S, Sassone-Corsi P. 2007. Circadian clock and breast cancer: a molecular link. Cell Cycle. 6:1329–1331.
  • Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 73:39–85.10.1146/annurev.biochem.73.011303.073723
  • Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. 2004. A functional genomics strategy reveals rora as a component of the mammalian circadian clock. Neuron. 43:527–537.10.1016/j.neuron.2004.07.018
  • Sato TK, Yamada RG, Ukai H, Baggs JE, Miraglia LJ, Kobayashi TJ, Welsh DK, Kay SA, Ueda HR, Hogenesch JB. 2006. Feedback repression is required for mammalian circadian clock function. Nat Genet. 38:312–319.10.1038/ng1745
  • Schibler U. 2003. Circadian rhythms: liver regeneration clock on. Science. 302:234–235.10.1126/science.1090810
  • Schibler U, Sassone-Corsi P. 2002. A web of circadian pacemakers. Cell. 111:919–922.
  • Shadan FF. 2007. Circadian tempo: a paradigm for genome stability? Med Hypotheses. 68:883–891.10.1016/j.mehy.2006.08.020
  • Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, Kume K, Lee CC, van-der-Horst GT, Hastings MH, Reppert SM. 2000. Interacting molecular loops in the mammalian circadian clock. Science. 288:1013–1019.10.1126/science.288.5468.1013
  • Shiekh MS, Garcia M, Pujol P, Fontana JA, Rochefort H. 1995. Why are estrogenreceptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis. 14:329–336.
  • Shirogane T, Jin J, Ang XL, Harper JW. 2005. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem. 280:26863–26872.10.1074/jbc.M502862200
  • Siepka SM, Yoo SH, Park J, Song W, Kumar V, Hu Y, Lee C, Takahashi JS. 2007. Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell. 129:1011–1023.10.1016/j.cell.2007.04.030
  • Slat E, Freeman GM Jr, Herzog ED. 2013. The clock in the brain: neurons, glia, andnetworks in daily rhythms. Handb Exp Pharmacol. 217:105–123.10.1007/978-3-642-25950-0
  • Spengler ML, Kuropatwinski KK, Comas M, Gasparian AV, Fedtsova N, Gleiberman AS, Gitlin II, Artemicheva NM, Deluca KA, Gudkov AV, Antoch MP. 2012. Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription. Proc Nat Acad Sci. 109:E2457–E2465.10.1073/pnas.1206274109
  • Stevens RG. 2005. Circadian disruption and breast cancer. Epidemiology. 16:254–258.10.1097/01.ede.0000152525.21924.54
  • Stevens RG, Rea MS. 2001. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 12:279–287.10.1023/A:1011237000609
  • Stier S, Totzke G, Gruewald E, Neuhaus T, Fronhoffs S, Schoneborn S, Vetter H, Ko Y. 2005. Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. J Biochem Mol Biol. 38:447–456.
  • Subramanian P, Jayapalan JJ, Hashim OH. 2014. Chronotherapy: a noteworthy focal point in the treatment of cancer. Biol Rhythm Res. 45:709–729.
  • Takahashi JS. 2015. Molecular components of the circadian clock in mammals. Diabetes Obes Metab. 17:6–11.10.1111/dom.2015.17.issue-S1
  • Tamai TK, Young LC, Cox CA, Whitmore D. 2012. Light acts on the zebrafish circadian clock to suppress rhythmic mitosis and cell proliferation. J Biol Rhythms. 27:226–236.10.1177/0748730412440861
  • Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. 2005. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol. 25:3109–3116.10.1128/MCB.25.8.3109-3116.2005
  • Wang Y, Rao VK, Kok WK, Roy DN, Sethi S, Ling BM, Lee MB, Taneja R. 2012. SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest. PLoS One. 7:e43137.10.1371/journal.pone.0043137
  • Welsh DK, Yoo S, Liu AC, Takahashi JS, Kay SA. 2004. Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression. Curr Biol. 14:2289–2295.10.1016/j.cub.2004.11.057
  • Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Pena MM, Hrushesky WJ. 2008. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 6:1786–1793.10.1158/1541-7786.MCR-08-0196
  • Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. 2000. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene. 19:6297–6305.10.1038/sj.onc.1204012
  • Xiang S, Coffelt SB, Mao L, Yuan L, Cheng Q, Hill SM. 2008. Period-2: a tumor suppressor gene in breast cancer. J Circadian Rhythms. 6:2–9.
  • Xiao L, Chang AK, Zang MX, Bi H, Li S, Wang M, Xing X, Wu H. 2014. Induction of the CLOCK Gene by E2-ERα signaling promotes the proliferation of breast cancer cells. PLoS One. 9:e95878.10.1371/journal.pone.0095878
  • Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptáček LJ, Fu YH. 2005. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 434:640–644.10.1038/nature03453
  • Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptáček LJ. 2007. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell. 128:59–70.10.1016/j.cell.2006.11.043
  • Yang Q, Pando BF, Dong G, Golden SS, van-Oudenaarden A. 2010a. Circadian gating of the cell cycle revealed in single cyanobacterial cells. Science. 327:1522–1526.10.1126/science.1181759
  • Yang X, Wood PA, Hrushesky WJ. 2010b. Mammalian TIMELESS is required for ATMdependent CHK2 activation and G2/M checkpoint control. J Biol Chem. 285:3030–3034.10.1074/jbc.M109.050237
  • Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJM. 2009. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 117:423–431.10.1007/s10549-008-0133-z
  • Yin L, Lazar MA. 2005. The orphan nuclear receptor Reverbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol. 19:1452–1459.10.1210/me.2005-0057
  • Yoo SH, Mohawk JA, Siepka SM, Shan Y, Huh SK, Hong HK, Kornblum I, Kumar V, Koike N, Xu M, et al. 2013. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell. 152:1091–1105.10.1016/j.cell.2013.01.055
  • Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ. 2010. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem. 148:319–326.10.1093/jb/mvq069
  • Zhu Y, Leaderer D, Guss C, Brown HN, Zhang Y, Boyle P, Stevens RG, Hoffman A, Qin Q, Han X, Zheng T. 2007. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non- Hodgkin’s lymphoma. Int J Cancer. 120:432–435.10.1002/(ISSN)1097-0215
  • Zhu Z, Brown HN, Zhang Y, Stevens RG, Zheng T. 2005. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers. 14:268–270.
  • Zhu Z, Stevens RG, Leaderer D, Hoffman AE, Holford T, Zhang Y, Brown HN, Zheng T. 2008. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat. 107:421–425.10.1007/s10549-007-9565-0
  • Zhu Z, Stevens RG, Hoffman AE, FitzGerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL. 2009. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 69:9315–9322.10.1158/0008-5472.CAN-09-0648
  • Zienolddiny S, Haugen A, Lie JA, Kjuus H, Anmarkrud KH, Kjærheim K. 2013. Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts. Breast Cancer Res. 15:R53.10.1186/bcr3445

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.